What is the recommended dose and duration of acyclovir for treating herpes infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for Herpes Infections

For treating herpes infections, acyclovir should be dosed at 200 mg orally five times daily for 5-14 days for genital herpes, 400 mg orally three times daily for 5-10 days for orolabial herpes, and 800 mg orally five times daily for 7-10 days for herpes zoster. 1, 2

Dosing Guidelines by Infection Type

Genital Herpes

  • Initial episode:
    • 200 mg orally every 4 hours, 5 times daily for 10 days 1
    • For immunocompromised patients: Consider IV acyclovir for severe cases 2

Orolabial Herpes (Cold Sores)

  • Treatment:
    • Adults: 400 mg orally three times daily for 5-10 days 2
    • Children: 20 mg/kg body weight (maximum 400 mg/dose) orally three times daily for 5-10 days 2

Herpes Zoster (Shingles)

  • Treatment: 800 mg orally every 4 hours, 5 times daily for 7-10 days 1, 3
    • Higher dose (800 mg) is significantly more effective than lower dose (400 mg) for zoster 3

Severe Mucocutaneous Lesions

  • Initial treatment: IV acyclovir until lesions begin to regress, then switch to oral therapy 2
  • Complete treatment: Continue until lesions have completely healed 2

Special Populations

Immunocompromised Patients

  • HIV-infected patients: Longer duration may be required; short-course therapy (1-3 days) should not be used 2
  • Severe cases: Consider IV acyclovir initially 2

Children

  • Moderate to severe gingivostomatitis:
    • Initial: Acyclovir 5-10 mg/kg IV three times daily
    • Switch to oral therapy when lesions begin to regress
    • Continue until lesions completely heal 2
  • Mild gingivostomatitis: Acyclovir 20 mg/kg (max 400 mg/dose) orally three times daily for 5-10 days 2

Suppressive Therapy

For patients with frequent recurrences (≥6 episodes per year):

  • Standard regimen: 400 mg orally twice daily for up to 12 months 1, 4
  • Alternative regimens: 200 mg 3-5 times daily 1
  • After 1 year, re-evaluate frequency and severity of infections 1

Renal Dose Adjustments

Creatinine Clearance 200 mg Regimen 400 mg Regimen 800 mg Regimen
>10 mL/min 200 mg q4h 400 mg q12h 800 mg q4h
0-10 mL/min 200 mg q12h 200 mg q12h 800 mg q12h

For patients on hemodialysis: Administer an additional dose after each dialysis session 1

Important Clinical Considerations

  1. Treatment initiation: Begin therapy at earliest signs or symptoms for maximum efficacy 4, 5

    • Starting within first 3 days of symptoms shortens duration of episode 6
  2. Treatment failure: Suspect resistance if lesions don't begin to resolve within 7-10 days of therapy 2

    • For suspected acyclovir-resistant HSV, obtain viral culture and consider foscarnet 2
  3. Monitoring:

    • For high-dose IV acyclovir: Monitor renal function at initiation and 1-2 times weekly 2
    • Ensure adequate hydration during treatment 4
  4. Common pitfalls:

    • Topical acyclovir alone is substantially less effective than systemic therapy 4
    • Short-course therapy is ineffective in immunocompromised patients 2
    • Treatment does not prevent virus latency or recurrent disease 5

The evidence clearly demonstrates that appropriate dosing and duration of acyclovir therapy significantly reduces viral shedding, speeds healing, and decreases pain associated with herpes infections 7, 5. While acyclovir effectively treats acute episodes, it does not eliminate the risk of future recurrences, which may require suppressive therapy in patients with frequent outbreaks 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Guideline

Management of Herpes Simplex Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of mucocutaneous herpes simplex infections with acyclovir.

Journal of the American Academy of Dermatology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.